What Researchers Did
Researchers conducted a literature review to estimate the economic costs associated with oral complications of cancer therapies, including mucositis, xerostomia, and osteonecrosis.
What They Found
They found that oral mucositis incurred incremental costs of $5,000-$30,000 for radiation patients and $3,700 per chemotherapy cycle, with mucositis-related hospitalizations exceeding $70,000 for stem cell transplant recipients. Managing osteoradionecrosis cost $4,000-$35,000, potentially reaching $74,000, with hyperbaric oxygen therapy adding $10,000-$50,000, while xerostomia management with sialogogues cost $40-$200 monthly.
What This Means for Canadian Patients
Canadian cancer patients experiencing oral complications like mucositis or xerostomia face substantial financial burdens due to treatment costs and potential hospitalizations. Recognizing these high costs can encourage Canadian healthcare systems to prioritize proactive prevention and effective management strategies to improve patient outcomes and reduce economic strain.
Canadian Relevance
This study did not include Canadian data or participants, therefore it has no direct Canadian connection.
Study Limitations
A limitation of this review is its reliance on existing literature, which may have varied methodologies and data sources, and the cost estimates are specific to US dollars.